Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The latest in multiple myeloma: a European and US perspective

Prof Paul Richardson and Prof Marivi Mateos

The latest in multiple myeloma: a European and US perspective ( Prof Paul Richardson and Prof Marivi Mateos )

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid...

Prof Susan Branford - Adelaide University Adelaide, Australia

Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ( Prof Susan Branford - Adelaide University Adelaide, Australia )

Advances in the treatment and management of CLL

Prof Clemens Wendtner and Prof Peter Hillmen

Advances in the treatment and management of CLL ( Prof Clemens Wendtner and Prof Peter Hillmen )

Transplantation combined with novel agents optimal treatment for multiple...

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

Transplantation combined with novel agents optimal treatment for multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

Monoclonal antibodies and multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

Monoclonal antibodies and multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

New definition for multiple myeloma improves patient outcomes

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

New definition for multiple myeloma improves patient outcomes ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

Factors influencing response to blinatumomab in relapsed/refractory ALL

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany

$Factors influencing response to blinatumomab in relapsed/refractory ALL ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )$

Evidence for kinase inhibitor activity in acute myeloid leukaemia

Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany

Evidence for kinase inhibitor activity in acute myeloid leukaemia ( Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany )

Targeted combination therapy with potential to eliminate relapsed chronic...

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia

Targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )

DNMT3A R882 mutations promote chemoresistance and residual disease in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )

Adding elotuzumab to standard treatment for multiple myeloma significantly...

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens...

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )

Treatment and survival of patients with chronic myeloid leukaemia in Europe

Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany

Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )

More from ecancer